Effect of AQW051 in Patients With Memory Impairment - Contacts and Locations - ClinicalTrials.gov

ClinicalTrials.gov

Home

Search


	Full Text View


	Tabular View


	Contacts and Locations


	No Study Results Posted


	Related Studies

Effect of AQW051 in Patients With Memory Impairment

This study is currently recruiting participants.

Study NCT00582855. Last updated on June 20, 2008. Information provided by Novartis

Please refer to this study by its ClinicalTrials.gov identifier: NCT00582855

Contacts


Contact: Novartis	+41 61 324 1111

Locations


Canada
	Novartis Investigator Site			Recruiting
	Montreal, Canada
	Contact: NOVARTIS 862 778 8300
	Novartis Investigator Site			Recruiting
	Toronto, Canada
	Contact: NOVARTIS 862 778 8300
	Novartis Investigator Site			Recruiting
	Halifax, Canada
	Contact: NOVARTIS 862 778 8300

United Kingdom
	Novartis Investigator Site			Recruiting
	Manchester, United Kingdom
	Contact: Novartis +41 61 324 1111
	Novartis Investigator Site			Recruiting
	Epping, United Kingdom
	Contact: NOVARTIS +41 61 324 1111
	Novartis Investigator Site			Recruiting
	Swindon, United Kingdom
	Contact: Novartis +41 61 324 1111
	Novartis Investigator Site			Recruiting
	Blackpool, United Kingdom
	Contact: Novartis +41 61 324 1111
	Novartis Investigator Site			Recruiting
	Glasgow, United Kingdom
	Contact: NOVARTIS +41 61 324 1111
	Novartis Investigator Site			Recruiting
	Southampton, United Kingdom
	Contact: NOVARTIS +41 61 324 1111

Sponsors and Collaborators

Novartis

Investigators


Principal Investigator:	Novartis	Novartis investigative site